David Clapham

David Clapham is a seasoned bioanalytical scientist currently serving as Principal Scientist and Principal Investigator at KCAS Bioanalytical & Biomarker Services since April 2023. With extensive experience in regulatory and scientific oversight, Clapham previously held roles as Bioanalytical Principal Investigator and Project Leader at Immunologix Laboratories from August 2015 to February 2023, contributing to assay development and validation. Earlier in the career, Clapham developed immunoassays at Immunetics, Inc., and performed assay validation at Percivia, LLC, Genzyme Corporation, and ARIAD Pharmaceuticals, Inc. Clapham also owned a consulting business in Japan and served as a Combat Medic in the US Army prior to starting a professional career. Clapham holds a Certificate in Clinical Research from Boston University School of Medicine and a B.A. in Biology from Saint Joseph's College.